B-PO01-029 CHRONIC RETRIEVABILITY OF A LEADLESS PACEMAKER: WORLDWIDE EXPERIENCE OUT TO 7 YEARS

Nanostim leadless pacemaker (LP; Abbott Inc) clinical trials were halted after 1,423 implants in 10/2016 due to premature battery depletion and a docking button detachment vulnerability. To describe the long-term worldwide experience with LP retrieval. Patients enrolled in multicenter LP clinical trials in the US, Canada, Europe, Japan, and Australia, and who underwent an LP retrieval attempt were included. Data were collected for each retrieval...